Bioprocessing Facilities Report

Asia Pacific Bioprocessing Facilities

$5,998$9,998

Featuring over 65 Bioprocessing Facilities from China, Taiwan, Korea, Japan, India, SEA, and Australia! Asia-Pacific Bioprocessing Facilities report covers comprehensive information on parameters such as facility sizecapacityproduction technologiestypes of biologics manufactured and much more. It provides readers a closer look into the facilities of ChugaiHanmiDaiichi SankyoBiocon (India & SEA), BeigeneAmgen (Singapore)GSK (Singapore) and more.

KEY TAKEAWAYS
  • Insights on production processes various BioPharmas currently and plan to employ.
  • Understand the facility expansion plans of key players in the industry.
  • Identify potential clients who would be interested in your latest technology or service.
  • The report also features checklists based on DesignFlex30 and highlights examples of companies that have constructed their facilities in a flexible manner catering to the fast-changing needs of the industry.
Clear
 
product details
  • 1Table of Contents
  • 2Companies Mentioned
  • 3User Access

Section 1

  • Preface
  • Report Scope & Data Coverage
  • IMAPAC’s Research Methodology

Section 2 - 5

  • Bioprocessing Facilities: Greater China, Korea, Japan, India, Australia, Southeast Asia

Section 6

  • Products Manufactured: Vaccines| Cell Therapy| Recombinant Proteins & Mabs | Others
  • Technologies Housed and Bioprocessing Processes
  • Plant Capacity
  • Projects In Pipeline
  • Biomanufacturing Investment
  • Regulatory Approvals
  • Facility Size, Design
  • Financial Insights
  • Pestel Analysis

Section 7

  • Bibiliography
  • Disclaimer
  • About Us
  • Our Other Reports

Bioprocessing Facilities: Greater China

  • Henlius Pharma
  • Innovent Biologics
  • Pfizer
  • Tonhua Dongbao
  • AlphaMab
  • Akeso Pharmaceuticals
  • Hanmi Pharma
  • Sinovac
  • BeiGene
  • Junshi Biosciences
  • Tot Biopharma
  • Hualan Biological Engineering

Bioprocessing Facilities: Korea and Japan

  • Samsung Bioepis
  • Astellas
  • Celltrion
  • Chugai
  • Hanmi Pharma
  • Kyowa Hakko Kirin
  • Aprogen Biologiccs
  • Daiichi Sankyo

Bioprocessing Facilities: India and Australia

  • Aurobindo
  • CSL Bering
  • Serum Institute of India
  • CSIRO
  • Enzene Biosciences
  • Stelis Biopharma

Bioprocessing Facilities: Southeast Asia

  • Abbvie
  • GSK
  • AJ Biologics
  • Amgen
  • Novartis Thailand
  • Baxter
  • Takeda
  • Siam Biosciences

Single - User Access

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Multi - User Access

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users of the same firm/enterprise.

Corporate Access

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

Related products
Southeast Asia Report
$5,998$9,998

Southeast Asia Bioprocessing Market

  • Region: Southeast Asia
  • Companies Featured: 25
  • Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
  • Topics: Bioprocessing Facilities Southeast Asia
CMO Biologics Report
$5,998$9,998

Asia-Pacific Biologic CMO Facilities

  • Region: APAC
  • Companies Featured: 42
  • Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
  • Topics: Biologics Contract Manufacturing Asia-Pacific
chat
Get In Touch

    padlock

    By clicking the "Submit" button, you are agreeing to IMAPAC's Privacy Policy.

    bag